SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 30 filers reported holding SILENCE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,819,216 | +80.0% | 3,443,912 | +0.8% | 1.73% | +96.2% |
| Q2 2023 | $18,784,480 | -8.0% | 3,415,360 | +3.7% | 0.88% | -12.6% |
| Q1 2023 | $20,419,111 | -58.4% | 3,293,405 | +2.3% | 1.01% | -49.3% |
| Q4 2022 | $49,077,550 | +51.9% | 3,218,200 | -0.0% | 1.99% | +19.0% |
| Q3 2022 | $32,307,000 | +8.9% | 3,219,400 | +106.2% | 1.68% | +47.2% |
| Q1 2022 | $29,669,000 | – | 1,561,551 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |